Marshall Wace, LLP Alpha Teknova, Inc. Transaction History
Marshall Wace, LLP
- $90.8 Billion
- Q3 2025
A detailed history of Marshall Wace, LLP transactions in Alpha Teknova, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 12,992 shares of TKNO stock, worth $57,294. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,992
Previous 90,032
85.57%
Holding current value
$57,294
Previous $442,000
83.26%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TKNO
# of Institutions
67Shares Held
6.93MCall Options Held
0Put Options Held
0-
Ubs Group Ag1.5MShares$6.62 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL987KShares$4.35 Million0.01% of portfolio
-
Roubaix Capital, LLC834KShares$3.68 Million2.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA626KShares$2.76 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC309KShares$1.36 Million0.03% of portfolio
About Alpha Teknova, Inc.
- Ticker TKNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 28,080,500
- Market Cap $124M
- Description
- Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...